556
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Minimal Clinically Important Difference in Barthel Index Dyspnea in Patients with COPD

ORCID Icon, , , , ORCID Icon, ORCID Icon, , , , ORCID Icon & show all
Pages 2591-2599 | Published online: 21 Oct 2020

References

  • ParshallMB, SchwartzsteinRM, AdamsL, et al. American Thoracic Society Committee on Dyspnea. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med. 2012;185(4):435–452. doi:10.1164/rccm.201111-2042ST22336677
  • AmbrosinoN, FracchiaC. Strategies to relieve dyspnoea in patients with advanced chronic respiratory diseases. A narrative review. Pulmonology. 2019;25(5):289–298. doi:10.1016/j.pulmoe.2019.04.00231129045
  • LavioletteL, LavenezianaP. Dyspnoea: a multidimensional and multidisciplinary approach. European Respiratory Journal. 2014;43(6):1750–1762. doi:10.1183/09031936.0009261324525437
  • MahlerDA. Measurement of dyspnea: clinical ratings In: MahlerDA, O’DonnellDE, editors. Dyspnea: Mechanisms, Measurement, and Management. 2nd ed. Boca Raton, FL: Taylor & Francis Group; 2005:147–166.
  • SpruitMA, SinghSJ, GarveyC, et al. ATS/ERS Task Force on Pulmonary Rehabilitation. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188(8):e13–e64. doi:10.1164/rccm.201309-1634ST24127811
  • McCarthyB, CaseyD, DevaneD, MurphyK, MurphyE, LacasseY. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2015;2:CD003793.
  • PaneroniM, SimonelliC, VitaccaM, AmbrosinoN. Aerobic Exercise Training in Very Severe Chronic Obstructive Pulmonary Disease. Am J Phys Med Rehabil. 2017;96(8):541–548. doi:10.1097/PHM.000000000000066728099192
  • 2019 Global strategy for prevention, diagnosis and management of COPD. http://goldcopd.org/gold-reports/. Accessed 528, 2020.
  • ShahS, VanclayF, CooperB. Improving the sensitivity of the Barthel Index for stroke rehabilitation. J Clin Epidemiol. 1989;42(8):703–709. doi:10.1016/0895-4356(89)90065-62760661
  • VitaccaM, PaneroniM, BaiardiP, et al. Development of a Barthel Index based on dyspnea for patients with respiratory diseases. Int J Chron Obstruct Pulmon Dis. 2016;11:1199–1206. doi:10.2147/COPD.S10437627354778
  • FletcherCM. Standardised questionnaire on respiratory symptoms: a statement prepared and approved by the MRC Committee on the aetiology of chronic bronchitis (MRC breathlessness score). Br Med J. 1960;2(5213):1665.13688719
  • De TorresJP, Pinto-PlataV, IngenitoE, et al. Power of outcome measurements to detect clinically significant changes in pulmonary rehabilitation of patients with COPD. Chest. 2002;121(4):1092–1098. doi:10.1378/chest.121.4.109211948037
  • MaestriR, BruschiC, FracchiaC, PinnaGD, FanfullaF, AmbrosinoN. Physiological and clinical characteristics of patients with COPD admitted to an inpatient pulmonary rehabilitation program: A real-life study. Pulmonology. 2019;25(2):71–78. doi:10.1016/j.pulmoe.2018.07.00130143469
  • LinnBS, LinnMW, GurelL. Cumulative illness rating scale. J Am Geriatr Soc. 1968;16(5):622–626. doi:10.1111/j.1532-5415.1968.tb02103.x5646906
  • MillerMR, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. doi:10.1183/09031936.05.0003480516055882
  • QuanjerPH, StanojevicS, ColeTJ, et al. Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324–1343. doi:10.1183/09031936.0008031222743675
  • JonesPW, HardingG, BerryP, WiklundI, ChenW-H, Kline LeidyN. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648–654. doi:10.1183/09031936.0010250919720809
  • HollandAE, SpruitMA, TroostersT, et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014;44(6):1428–1446. doi:10.1183/09031936.0015031425359355
  • MaltaisF, LeBlancP, JobinJ, et al. Intensity of training and physiologic adaptation in patients with chronic obstructive pulmonary disease.. Am J Respir Crit Care Med. 1997;155(2):555–561. doi:10.1164/ajrccm.155.2.90321949032194
  • LuxtonN, AlisonJA, WuJ, MackeyMG. Relationship between field walking tests and incremental cycle ergometry in COPD. Respirology. 2008;13(6):856–862. doi:10.1111/j.1440-1843.2008.01355.x18811884
  • KonS, CanavanJL, JonesSE, et al. Minimum clinically important difference for the COPD Assessment Test: a prospective analysis. Lancet Respir Med. 2014;2(3):195–203. doi:10.1016/S2213-2600(14)70001-324621681
  • MahlerDA, WitekTJ. The MCID of the transition dyspnea index is a total score of one unit. COPD. 2005;2(1):99–103. doi:10.1081/COPD-20005066617136969
  • KupferbergDH, KaplanRM, SlymenDJ, RiesAL. Minimal clinically important difference for the UCSD Shortness of Breath Questionnaire. J Cardiopulm Rehabil. 2005;25(6):370–377.16327533
  • SchunemannHJ, PuhanM, GoldsteinR, JaeschkeR, GuyattGH. Measurement properties and interpretability of the Chronic Respiratory Disease Questionnaire (CRQ). COPD. 2005;2(1):81–89. doi:10.1081/COPD-20005065117136967
  • SchunemannHJ. Evaluation of the minimal important difference for the feeling thermometer and the St. George’s Respiratory Questionnaire in patients with chronic airflow obstruction. J Clin Epidemiol. 2003;56(12):1170–1176. doi:10.1016/S0895-4356(03)00115-X14680667
  • RevickiD, HaysRD, CellaD, SloanJ. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol. 2008;61(2):102–109.18177782
  • CaroneM, PatessioA, AmbrosinoN, et al. Efficacy of pulmonary rehabilitation in chronic respiratory failure (CRF) due to chronic obstructive pulmonary disease (COPD): the Maugeri Study. Respir Med. 2007;101(12):2447–2453. doi:10.1016/j.rmed.2007.07.01617728121
  • JonesPW, BeehKM, ChapmanKR, DecramerM, MahlerDA, WedzichaJA. Minimal clinically important differences in pharmacological trials. Am J Respir Crit Care Med. 2014;189(3):250–255. doi:10.1164/rccm.201310-1863PP24383418
  • OliveiraA, MachadoA, MarquesMA. Minimal Important and Detectable Differences of Respiratory Measures in Outpatients with AECOPD †. COPD. 2018;15(5):479–488. doi:10.1080/15412555.2018.153736630512981
  • Almeida GulartA, de AraujoCLP, Bauer MunariA, SchneiderBF, Dal LagoP, MayerAF. Minimal important difference for London Chest Activity of Daily Living scale in patients with chronic obstructive pulmonary disease. Physiotherapy. 2019;107:28–35.32026830